Abstract
Otitis media is a common pediatric disease and the main reason for antibiotic prescription in children. Before implementation of routine childhood pneumococcal vaccination in Germany, serotypes contained in the seven-valent pneumococcal conjugate vaccine (PCV) were among the most frequent pneumococcal serotypes responsible for acute otitis media (AOM). This report describes the first 3 years of a prospective, multicenter, epidemiological cross-sectional study examining the bacteriology of middle ear fluids (MEF) and nasopharyngeal swabs (NPS) of children 2 months to 5 years of age with spontaneously perforated AOM in the era of routine pneumococcal vaccination. MEF was obtained from 963 subjects; NPS from 877. Reported case numbers steeply decreased over the three study years even though the recruiting base remained the same. Among subjects with relevant bacterial growth in their MEF swabs, 113 (11.7 %) had Streptococcus pyogenes, 97 (10.1 %) Staphylococcus aureus, 88 (9.1 %) Streptococcus pneumoniae, 63 (6.5 %) Haemophilus influenzae, and 8 (0.8 %) Moraxella catarrhalis. S. pneumoniae isolates decreased from 41 (9.3 %) in year 1 to 12 (5.7 %) in year 3 (p = 0.128). PCV7 serotypes accounted for only 7.9 % (n = 7) of isolated pneumococci. Of the 877 subjects with NPS cultures, 465 (53.0 %) carried S. pneumoniae, 314 (35.8 %) H. influenzae, 292 (33.3 %) M. catarrhalis, and 110 (12.5 %) S. pyogenes; 79.4 % (n = 765) of the children were vaccinated with at least one dose of PCV. Carriage of pneumococci was slightly lower in vaccinated (47.8 %) than in unvaccinated (52.7 %) children (p = 0.254). PCV7 serotypes were carried by 9.6 % of unvaccinated children but by only 4.2 % of vaccinated children, resulting in a 56.3 % vaccine effectiveness.
Conclusions: Following universal PCV7 immunization, a clear epidemiological impact of pneumococcal conjugate vaccination was observed as PCV7 serotypes have almost disappeared among AOM.
Similar content being viewed by others
Abbreviations
- AOM:
-
Acute otitis media
- GAS:
-
Group A Streptococcus
- IPD:
-
Invasive pneumococcal disease
- MEF:
-
Middle ear fluid
- NIP:
-
National immunization program
- NIPD:
-
Noninvasive pneumococcal disease
- NPS:
-
Nasopharyngeal swab
- NT-H. influenzae :
-
Nontypeable Haemophilus influenzae
- PCV:
-
Pneumococcal conjugate vaccine
- PNSP:
-
Penicillin nonsusceptible Streptococcus pneumoniae
References
(STIKO) S (2006) Empfehlungen der Ständigen Impfkommission (STIKO) am RKI (Stand Juli 2006):Begründungen zur allgemeinen Empfehlung der Impfung gegen Pneumokokken- und Meningokokken im Säuglings- und Kindesalter. Epidemiol Bull:255–260
(STIKO) S (2009) Mitteilung der STIKO zur Impfung gegen invasive Pneumokokken-Infektionen bei Kindern unter 24 Monaten, bei denen die Impfserie mit dem konjugierten 7-valenten Impfstoff begonnen wurde. Epidemiol Bull 49:507
Adam D (2002) Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 50(Suppl 1):1–5
American Academy of Family Physicians, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics Subcommittee on Otitis Media with Effusion (2004) Otitis media with effusion. Pediatrics 113:1412–1429
Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, Malinoski F, Madore D, Chang I, Kohberger R, Watson W, Austrian R, Edwards K (2000) Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 19:187–195
Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, Keegan E (2002) Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J 21:859–865
Bluestone CD, Klein JO (1995) Otitis media in infants and children. Philadelphia
Bogaert D, Hermans PW, Adrian PV, Rumke HC, de Groot R (2004) Pneumococcal vaccines: an update on current strategies. Vaccine 22:2209–2220
Broome CV, Facklam RR, Fraser DW (1980) Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303:549–552
Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR (1995) Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978–1994: implications for development of a conjugate vaccine. J Infect Dis 171:885–889
Chen YY, Yao SM, Chou CY, Chang YC, Shen PW, Huang CT, Su HP, Li SY (2006) Surveillance of invasive Streptococcus pneumoniae in Taiwan, 2002–2003. J Med Microbiol 55:1109–1114
Choi EH, Kim SH, Eun BW, Kim SJ, Kim NH, Lee J, Lee HJ (2008) Streptococcus pneumoniae Serotype 19A in children, South Korea. Emerg Infect Dis 14:275–281
Cohen R, Levy C, Thollot F, de La Rocque F, Koskas M, Bonnet E, Fritzell B, Varon E (2007) Pneumococcal conjugate vaccine does not influence Staphylococcus aureus carriage in young children with acute otitis media. Clin Infect Dis 45:1583–1587
Dagan R, Fraser D (2000) Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immmunity and reduction of otitis morbidity [in process citation]. Pediatr Infect Dis J 19:S79–S87, discussion S88
Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N (2009) Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 199:776–785
Diel M, Laurenz M, Krause K, Sprenger R, Busse A (2013) Impact of pneumococcal conjugate vaccines on acute otitis media among children in Germany. Paper presented at European Society for Peadiatric Infectious Diseases (ESPID). Milan, Italy, 31.05.2013
Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344:403–409
Fenoll A, Granizo JJ, Aguilar L, Gimenez MJ, Aragoneses-Fenoll L, Hanquet G, Casal J, Tarrago D (2009) Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 47:1012–1020
Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P (2003) Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22:10–16
Fletcher MA, Fritzell B (2007) Brief review of the clinical effectiveness of PREVENAR against otitis media. Vaccine 25:2507–2512
Imöhl M, Reinert RR, Ocklenburg C, van der Linden M (2010) Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003–2007. FEMS Immunol Med Microbiol 58:389–396
Imöhl M, Reinert RR, van der Linden M (2010) Temporal variations among invasive pneumococcal disease serotypes in children and adults in Germany (1992–2008). Int J Microbiol 2010:874189
Imöhl M, Reinert RR, van der Linden M (2010) Serotype-specific penicillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. Int J Med Microbiol 300:324–330
Marchisio P, Bianchini S, Baggi E, Fattizzo M, Galeone C, Torretta S, Principi N, Esposito S (2013) A retrospective evaluation of microbiology of acute otitis media complicated by spontaneous otorrhea in children living in Milan, Italy. Infection 41:629–635
Obaro SK, Adegbola RA, Banya WA, Greenwood BM (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348:271–272
Obaro SK, Monteil MA, Henderson DC (1996) The pneumococcal problem. BMJ 312:1521–1525
Podbielski A, Melzer B, Lütticken R (1991) Application of the polymerase chain reaction to study the M protein(−like) gene family in beta-hemolytic streptococci. Med Microbiol Immunol 180:213–227
Pumarola F, Mares J, Losada I, Minguella I, Moraga F, Tarrago D, Aguilera U, Casanovas JM, Gadea G, Trias E, Cenoz S, Sistiaga A, Garcia-Corbeira P, Pircon JY, Marano C, Hausdorff WP (2013) Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era. Int J Pediatr Otorhinolaryngol 77:1231–1236
Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M (2014) Update on otitis media—prevention and treatment. Infect Drug Resist 7:15–24
Segal N, Givon-Lavi N, Leibovitz E, Yagupsky P, Leiberman A, Dagan R (2005) Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis 41:35–41
Stamboulidis K, Chatzaki D, Poulakou G, Ioannidou S, Lebessi E, Katsarolis I, Sypsa V, Tsakanikos M, Kafetzis D, Tsolia MN (2011) The impact of the heptavalent pneumococcal conjugate vaccine on the epidemiology of acute otitis media complicated by otorrhea. Pediatr Infect Dis J 30:551–555
van der Linden M, Reinert RR (2010) Serotype distribution in pneumococcal acute otitis media with ruptured tympanic membrane or sepsis in Germany. Eur J Clin Microbiol Infect Dis 29:749–754
Wald ER, Mason EO Jr, Bradley JS, Barson WJ, Kaplan SL (2001) Acute otitis media caused by Streptococcus pneumoniae in children’s hospitals between 1994 and 1997. The US Pediatric Multicenter Pneumococcal Surveillance Group. Pediatr Infect Dis J 20:34–39
Zhou F, Shefer A, Kong Y, Nuorti JP (2008) Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics 121:253–260
Acknowledgments
We thank Stephanie Perniciaro for assistance with statistical calculations and critically reading the manuscript and improving the English language. This study was financed by Pfizer Pharma GmbH Germany. We sincerely thank all actively participating study sites.
Conflict of interest
ML, MR, AB, and DA have been members of advisory boards of Pfizer Pharma GmbH Germany.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Peter de Winter
Author’s summary
This study examines the bacteriology of middle ear fluids and nasopharyngeal carriage of children with spontaneously perforated AOM, thus providing surveillance data on pneumococcal disease and carriage in the era of routine pneumococcal vaccination in Germany.
Following universal PCV7 immunization, a clear epidemiological impact of pneumococcal conjugate vaccination was observed, as PCV7 serotypes have almost disappeared among AOM. Among the remaining serotypes, 3 and 19A are the most prevalent, indicating the added value of higher-valent pneumococcal conjugate vaccination. Concerning carriage, the percentage of children carrying pneumococci has not changed. However, the serotype distribution of carriage has strongly shifted toward non-PCV7 serotypes, showing that vaccination has the ability to replace serotypes common in AOM with ones that are probably less harmful. This might particularly be the case after the effects of PCV13 vaccination on AOM become visible in the next study years.
Mark van der Linden and Matthias Imöhl contributed equally to this study.
Rights and permissions
About this article
Cite this article
van der Linden, M., Imöhl, M., Busse, A. et al. Bacterial spectrum of spontaneously ruptured otitis media in the era of pneumococcal conjugate vaccination in Germany. Eur J Pediatr 174, 355–364 (2015). https://doi.org/10.1007/s00431-014-2409-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-014-2409-0